Search details
1.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
N Engl J Med
; 384(12): 1101-1112, 2021 03 25.
Article
in English
| MEDLINE | ID: mdl-33761207
2.
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
Acta Derm Venereol
; 103: adv5382, 2023 Apr 21.
Article
in English
| MEDLINE | ID: mdl-37083095
3.
Atopic dermatitis in skin of colour. Part 2: considerations in clinical presentation and treatment options.
Clin Exp Dermatol
; 48(10): 1091-1101, 2023 Sep 19.
Article
in English
| MEDLINE | ID: mdl-37119261
4.
Atopic dermatitis in skin of colour. Part 1: new discoveries in epidemiology and pathogenesis.
Clin Exp Dermatol
; 48(6): 609-616, 2023 Jun 05.
Article
in English
| MEDLINE | ID: mdl-37002798
5.
Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis.
J Allergy Clin Immunol
; 150(4): 882-893, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35568077
6.
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.
J Am Acad Dermatol
; 87(4): 815-824, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35863467
7.
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
Acta Derm Venereol
; 102: adv00830, 2022 Dec 07.
Article
in English
| MEDLINE | ID: mdl-36479885
8.
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies.
Acta Derm Venereol
; 101(2): adv00402, 2021 Feb 17.
Article
in English
| MEDLINE | ID: mdl-33491094
9.
Dupilumab in Chronic Actinic Dermatitis: a retrospective case series.
Br J Dermatol
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38656979
10.
Neutropenia in patients on dupilumab for atopic dermatitis: a case series and review of trial data.
Br J Dermatol
; 188(6): 803-805, 2023 05 24.
Article
in English
| MEDLINE | ID: mdl-36930577
11.
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic.
Br J Dermatol
; 188(4): 471-473, 2023 03 30.
Article
in English
| MEDLINE | ID: mdl-36715624
12.
English Sunday lunch dermatitis: Allergic contact dermatitis to parsnip, carrot, fennel (and ivy).
Contact Dermatitis
; 83(4): 317-318, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32383193
13.
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.
Am J Hum Genet
; 89(3): 432-7, 2011 Sep 09.
Article
in English
| MEDLINE | ID: mdl-21839423
14.
Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
Arch Dermatol Res
; 316(7): 380, 2024 Jun 08.
Article
in English
| MEDLINE | ID: mdl-38850461
15.
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.
Skin Health Dis
; 4(3): e359, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38846692
16.
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Dermatol Ther (Heidelb)
; 14(5): 1127-1144, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38696027
17.
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
JAMA Dermatol
; 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38691347
18.
Remission of chronic actinic dermatitis on baricitinib: A case report.
Skin Health Dis
; 3(6): e243, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38047267
19.
Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin-Induced Adverse Ocular Events-Incidence, Etiology, and Management.
Cornea
; 42(4): 507-519, 2023 Apr 01.
Article
in English
| MEDLINE | ID: mdl-36525340
20.
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.
Dermatol Ther (Heidelb)
; 13(9): 1893-1907, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37482564